Floatz logo

Wellbutrin

Advanced Solid Tumor

Jiangsu HengRui Medicine Co., Ltd.Phase 3Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
59/ 100

Competitive context

547 Active assets in the Advanced Solid Tumor cohort.

Asset / SponsorPhaseRating
Toripalimab
Nanjing Immunophage Biotech Co., Ltd
Phase 2B
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3B
Pyrotinib
LaNova Medicines Limited
Phase 3B
rc48-adc
LaNova Medicines Limited
Phase 3B
LENVATINIB
LaNova Medicines Limited
Phase 2B

View all 50 →

Same molecule, other indications

Wellbutrin is also rated in:

Smoking CessationDormant
A
Indicative ·
82 / 100
View asset →
DysthymiaDormant
BBB
Indicative ·
73 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →